Thrombosis prevention around the world
Tracks
Track 1
| Monday, April 29, 2024 |
| 5:15 PM - 6:15 PM |
| Hall 1B |
Details
This session will cover VTE prevention diagnosis and treatment in Antarctica as well as looking at a trial around chemical prophylaxis in older medical patients comparing the use of low molecular weight heparin with no prophylaxis and examining thrombosis and bleeding risk in both groups
Speaker
Prof. Gregoire Le Gal
Physician
University Of Ottawa
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients
Mr. Tim Parham
Matron
British Antarctic Survey Medical Unit
VTE in the Antarctic: Diagnosis treatment and incidence
Chair
Huw Rowswell
Consultant Nurse
University Hospitals Plymouth
